aav gene therapies for hemophilia a and b
Published 1 year ago • 442 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
3:07
aav-based gene therapy in hemophilia a and b: valoctocogene roxaparvovec & etranacogene dezaparvovec
-
2:23
current hurdles in aav-based gene therapy for hemophilia
-
10:42
a detailed overview of the current and emerging gene therapies for hemophilia a & b
-
6:27
adeno-associated virus mediated gene transfer for hemophilia b
-
1:23
the present and future of hemophilia a treatment
-
1:35
improved quality of life in patients with hemophilia a following gene therapy
-
1:27
the challenges of implementing gene therapies for hemophilia in clinical practice
-
1:43
quality of life in patients with hemophilia: the impact of bleeds & the benefits of gene therapy
-
1:11
improving outcomes for hemophilia patients through the implementation of gene therapies
-
1:09
highlights from isth: gene therapy in hemophilia a & undiagnosed bleeding disorders in pediatrics
-
1:01
gene therapy as a future treatment for hemophilia
-
3:57
first-in-human gene therapy study of peboctocogene camaparvovec (bay 2599023) in severe hemophilia a
-
1:12
promising novel agents for hemophilia a/b: gene therapies and extended half-life products
-
0:57
aav gene transfer for hemophilia
-
20:34
gene therapy for treatment of hemophilia: aav vector gene therapy application to hemophilia
-
2:11
improved joint health following dirloctocogene samoparvovec gene therapy in patients with hemophilia
-
1:11
current treatment options for hemophilia a
-
0:54
immune response monitoring in patients with hemophilia treated with gene therapy
-
36:32
gene therapy for fviii